Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Sale of product	$ 1,936,481	$ 1,948,856
Cost of product	1,125,943	1,144,428
Gross profit	810,538	804,428
Operating costs and expenses:
Salaries and contract labor	408,184	387,358
General, administrative and consulting	376,696	507,222
Research and development	92,747	81,947
Total operating expenses	877,627	976,527
Net operating loss	(67,089)	(172,099)
Other income (expense):
Other income (expense)	6,955	5,283
Equity in net income of affiliate	34,693	21,580
Interest income	92	295
Interest expense	(141,124)	(309,669)
Total other income (expense)	(99,384)	(282,511)
Net loss	(166,473)	(454,610)
Loss (income) attributable to non-controlling interest	(5,075)	2,405
Net loss attributable to International Isotopes Inc.	$ (171,548)	$ (452,205)
Net loss per common share - basic and diluted	$ 0.00	$ 0.00
Weighted average common shares outstanding - basic and diluted	386,006,105	369,150,813